TransFlex human MATE2-K (SLC47A2) plates are available in a 96-well format with variable plate configurations. The plates are ready to use after an overnight incubation—no change of medium required.
In the graph above, TransFlex-MATE2-K plate performance is demonstrated by MATE2-K-mediated transport of metformin, and inhibition of that transport by the MATE2-K inhibitor cimetidine.
|Catalog Number||Plate Configuration|
|TFlex- MATE2-K||Half of the wells contain MATE2-K-expressing cells, and half contain control cells.|
|TFlex- MATE2-K-F||All of the wells contain MATE2-K-expressing cells.|
|TFlex-MDCK-C||All of the wells contain control cells.|
|TFlex-Pick2||Custom format: plate contains two transporters of your choice, plus control cells.|
|TFlex-Pick4||Custom format: plate contains four transporters of your choice, plus control cells.|
Please contact us for more information.